Piramal Pharma在密歇根州和肯塔基州投资90万加元,以扩大药物制造能力。 Piramal Pharma invests $90M in Michigan and Kentucky to expand drug manufacturing capacity.

Piramal Pharma Solution计划将其在密歇根和肯塔基的设施扩大9 000万美元,以提高高能力API和消毒注射器的生产能力。 Piramal Pharma Solutions plans a $90 million expansion of its facilities in Michigan and Kentucky to boost manufacturing capabilities for high-potency APIs and sterile injectables. 密歇根站点将增加一套有效载荷连接器开发套件,而肯塔基站点将扩大24 000平方米,包括新实验室和先进机械。 The Michigan site will add a suite for payload-linker development, while the Kentucky site will expand by 24,000 sq ft, including new labs and advanced machinery. 这种扩大支持了无菌注射器市场在医疗需要和监管批准增加的驱动下不断增长的需求。 This expansion supports growing demand in the sterile injectables market, driven by increased medical needs and regulatory approvals.